From professional translators, enterprises, web pages and freely available translation repositories.
sofosbuviiri
sofosbuvir
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
sofosbuviiri:
ledipasvir:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sofosbuviiri: auc: ↔
sofosbuvir: auc: ↔
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
daklinza + sofosbuviiri
daklinza +sofosbuvir
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sof = sofosbuviiri; b.
sof = sofosbuvir; b.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daklatasviir i + sofosbuviiri
+ sofosbuvir
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaikuttava aine on sofosbuviiri.
the active substance is sofosbuvir.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
epclusa sofosbuviiri/velpatasviiri
epclusa sofosbuvir / velpatasvir
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daklinza + sofosbuviiri + ribaviriini
daklinza +sofosbuvir + ribavirin n=203
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ledipasviiri/sofosbuviiri (90 mg /
ledipasvir/sofosbuvir (90 mg/400 mg once daily) +
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sofosbuviiri on nukleotidirakenteinen aihiolääke.
sofosbuvir is a nucleotide prodrug.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daklatasviiri + sofosbuviiri 12 viikkoa
daclatasvir + sofosbuvir 12 weeks
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daklinza + sofosbuviiri 12 viikon ajan
daklinza + sofosbuvir for 12 weeks
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sovaldi 400 mg kalvopäällysteiset tabletit sofosbuviiri
sovaldi 400 mg film-coated tablets sofosbuvir
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaikuttavat aineet ovat ledipasviiri ja sofosbuviiri.
the active substances are ledipasvir and sofosbuvir.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sofosbuviiri ja ribaviriini 12 viikon ajan (132)
sof+rbv 12 weeks (132)
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
epclusan vaikuttavat aineet ovat sofosbuviiri ja velpatasviiri.
epclusa contains the active substances sofosbuvir and velpatasvir.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
daklinza + sofosbuviiri + ribaviriini 12 viikon ajan tai
daklinza + sofosbuvir + ribavirin for 12 weeks or
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sofosbuviiri sai myyntiluvan sovaldi-nimisenä tammikuussa 2014.
sofosbuvir has been authorised as sovaldi since january 2014.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
0,025 mg)/ sofosbuviiri (400 mg kerran vuorokaudessa)d
0.025 mg)/ sofosbuvir (400 mg once daily)d
Last Update: 2017-04-26
Usage Frequency: 1
Quality: